These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33705948)

  • 1. Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment.
    Vazhappilly CG; Amararathna M; Cyril AC; Linger R; Matar R; Merheb M; Ramadan WS; Radhakrishnan R; Rupasinghe HPV
    J Nutr Biochem; 2021 Aug; 94():108623. PubMed ID: 33705948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids in cancer prevention.
    Park EJ; Pezzuto JM
    Anticancer Agents Med Chem; 2012 Oct; 12(8):836-51. PubMed ID: 22292763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering flavonoids into solid tumors using nanotechnologies.
    Wang S; Zhang J; Chen M; Wang Y
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1411-28. PubMed ID: 23862581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches.
    Hussain Y; Luqman S; Meena A
    Curr Top Med Chem; 2020; 20(20):1791-1809. PubMed ID: 32357817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.
    Khan H; Ullah H; Martorell M; Valdes SE; Belwal T; Tejada S; Sureda A; Kamal MA
    Semin Cancer Biol; 2021 Feb; 69():200-211. PubMed ID: 31374244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
    Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
    Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action.
    Mani R; Natesan V
    Phytochemistry; 2018 Jan; 145():187-196. PubMed ID: 29161583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystal technology for improving therapeutic efficacy of flavonoids.
    Gujar K; Wairkar S
    Phytomedicine; 2020 Jun; 71():153240. PubMed ID: 32450461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview.
    Zhao J; Yang J; Xie Y
    Int J Pharm; 2019 Oct; 570():118642. PubMed ID: 31446024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-soldiers Ameliorate Silibinin Delivery: A Review Study.
    Ashrafizadeh M; Ahmadi Z; Mohammadinejad R; Farkhondeh T; Samarghandian S
    Curr Drug Deliv; 2020; 17(1):15-22. PubMed ID: 31721702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent discoveries of anticancer flavonoids.
    Raffa D; Maggio B; Raimondi MV; Plescia F; Daidone G
    Eur J Med Chem; 2017 Dec; 142():213-228. PubMed ID: 28793973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer.
    Khushnud T; Mousa SA
    Mol Biotechnol; 2013 Sep; 55(1):78-86. PubMed ID: 23371307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of flavonoids impacts their efficacy and safety.
    Ma Y; Zeng M; Sun R; Hu M
    Curr Drug Metab; 2014; 15(9):841-64. PubMed ID: 25658129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary flavonoids: bioavailability, metabolic effects, and safety.
    Ross JA; Kasum CM
    Annu Rev Nutr; 2002; 22():19-34. PubMed ID: 12055336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlocking the potential of flavonoid-based co-crystal and co-amorphous systems.
    Rode K; Maji I; Mahajan S; Singh PK
    Drug Discov Today; 2024 Jul; 29(7):104050. PubMed ID: 38830502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of Flavonoids and Tannins from Medicinal Plants as Anticancer Agents.
    Teodor ED; Ungureanu O; Gatea F; Radu GL
    Anticancer Agents Med Chem; 2020; 20(18):2216-2227. PubMed ID: 32416704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure-activity/property relationship-based approach in the study of bioavailability and bioactivity.
    Gonzales GB; Smagghe G; Grootaert C; Zotti M; Raes K; Van Camp J
    Drug Metab Rev; 2015 May; 47(2):175-90. PubMed ID: 25633078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
    Brand W; Schutte ME; Williamson G; van Zanden JJ; Cnubben NH; Groten JP; van Bladeren PJ; Rietjens IM
    Biomed Pharmacother; 2006 Nov; 60(9):508-19. PubMed ID: 16978825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
    Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids: prospective drug candidates.
    Cazarolli LH; Zanatta L; Alberton EH; Figueiredo MS; Folador P; Damazio RG; Pizzolatti MG; Silva FR
    Mini Rev Med Chem; 2008 Nov; 8(13):1429-40. PubMed ID: 18991758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.